FDA approves first e-cigarettes

DMCA / Correction Notice
- Advertisement -


The Food and Drug Administration on Tuesday authorized three electronic cigarette products by Vus Solo, citing benefits to adult smokers trying to quit tobacco.

- Advertisement -

why it matters: This is the first such step by the agency in its effort to regulate new tobacco products. While e-cigarette manufacturers tout vape products as safe, the FDA has previously cracked down on them amid high rates of use among teens.

  • According to an FDA press release, the products must be approved by the FDA to claim that they help users quit smoking.

description: In a first green light when the FDA prompted e-cigarette manufacturers to apply for approval, the agency approved Vuss Solo brand devices, which are distributed by RJ Reynolds, a division of British American Tobacco.

  • Only the tobacco-flavored pods were allowed to proceed.
  • The FDA also declined applications for 10 flavored Vuse Solo products.
  • Tuesday’s action imposes tighter marketing restrictions aimed at curbing “youth exposure to tobacco advertising,” the FDA said. in a statement announcing his decision.
advertisement

of note: The FDA stated that the aerosols of the authorized products are “significantly less toxic than combustible cigarettes based on available data.”

What are they saying: “Today’s authorization is an important step toward ensuring all new tobacco products undergo the FDA’s robust, scientific pre-evaluation,” Mitch Zeller, director of the FDA’s Center for Tobacco Products, said in a statement.

  • Zeller said, “The manufacturer’s data suggests that its tobacco-flavored products may benefit addicted adult smokers who switch to these products – either completely or through a significant reduction in cigarette consumption.” With – by reducing exposure to harmful chemicals.”
- Advertisement -

go in: FDA needs more time on Juul e-cigarette ban decision

See Nerdshala’ full coverage on Vaping

.

- Advertisement -

Stay on top - Get the daily news in your inbox

Recent Articles

Related Stories